A Global Shift in Strategy
In response to a quadrupling of childhood obesity rates since 1990, the WHO has established new global standards for how to care for children and adolescents living with obesity. The guidelines, released on October 7, 2026, represent a significant philosophical
change. They move away from a primary focus on weight loss and instead champion a holistic, 'person-centered' approach that prioritizes comprehensive support for the child and their family. The core message is clear: the foundation of care is not medicine or surgery, but creating access to healthy eating, physical activity, and sustainable behavioural support. This is a strong recommendation designed to address the estimated 170 million children and teens worldwide living with obesity.
The 'Lifestyle First' Mandate
The new guidance strongly recommends that any treatment must begin with what it calls a multimodal lifestyle program. This isn't just a simple suggestion to 'eat less and move more'. Instead, it calls for structured, supervised interventions that combine dietary changes, physical activity plans, and behavioural support. For children, this means involving parents and caregivers directly in programs supervised by trained health workers. The WHO emphasizes that interventions should be tailored to the individual, considering their age, culture, food preferences, and family resources. The guidance also acknowledges that digital tools, like activity-tracking apps or active video games, can be useful additions, but only with caregiver supervision to manage screen time.
The Narrow Path to Medication
The most significant change is the strict new limits on when medicines may be considered. For children under the age of 10, the WHO strongly recommends against the use of any pharmacological treatments, bariatric surgery, or weight-management devices. For adolescents aged 10 to 19, the guidelines state that approved medicines like GLP-1 drugs can be considered, but only under specific conditions. Medication should only be an option after a comprehensive, supervised lifestyle program has failed to achieve the desired results. Furthermore, the adolescent must be physically and psychologically prepared for the treatment. This cautious stance is due to the limited long-term data on the safety and efficacy of these powerful drugs in growing children.
Why the Caution Around Drugs?
The WHO's conservative approach stems from a lack of long-term evidence and concerns about the potential for 'over-medicalization'. While drug companies are testing medications in children as young as six, the WHO notes that there is uncertainty about long-term effects on growth, development, and mental health. A key concern is that some weight-loss drugs work by significantly reducing caloric intake, which could lead to nutritional deficiencies that harm a child's development. The guidelines are a direct response to the soaring use of these drugs in some countries, aiming to ensure that lifestyle and environmental factors are addressed first, rather than turning immediately to a prescription.
Implications for Families in India
These global guidelines are particularly relevant for India, which faces a 'dual burden' of undernutrition and a rapid rise in childhood obesity. Recent data shows a significant increase in obesity among Indian children and adolescents over the last three decades. The WHO's emphasis on holistic care aligns with the challenges many Indian families face, where lifestyle shifts are driven by increased access to processed foods and more sedentary habits. For parents in India, this guidance reinforces the message that the first and most important steps are to focus on balanced nutrition, encouraging physical activity, and building healthy family habits. It's a call to view obesity not as a simple problem of weight, but as a complex health issue that requires sustained support and addresses the child's overall physical and mental well-being.
